Correlation Between Molecular Pharmacology and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Molecular Pharmacology and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Pharmacology and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Pharmacology and NewAmsterdam Pharma, you can compare the effects of market volatilities on Molecular Pharmacology and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Pharmacology with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Pharmacology and NewAmsterdam Pharma.
Diversification Opportunities for Molecular Pharmacology and NewAmsterdam Pharma
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Molecular and NewAmsterdam is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Pharmacology and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Molecular Pharmacology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Pharmacology are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Molecular Pharmacology i.e., Molecular Pharmacology and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Molecular Pharmacology and NewAmsterdam Pharma
If you would invest 1,913 in NewAmsterdam Pharma on August 28, 2024 and sell it today you would earn a total of 192.00 from holding NewAmsterdam Pharma or generate 10.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Pharmacology vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Molecular Pharmacology |
| NewAmsterdam Pharma |
Molecular Pharmacology and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Pharmacology and NewAmsterdam Pharma
The main advantage of trading using opposite Molecular Pharmacology and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Pharmacology position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| Molecular Pharmacology vs. Curative Biotechnology | Molecular Pharmacology vs. Kineta Inc | Molecular Pharmacology vs. Vertex Pharmaceuticals | Molecular Pharmacology vs. BioNTech SE |
| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |